麻豆传媒

The CIHR Institute of Cancer Research (ICR) and Institute of Neurosciences, Mental Health and Addiction (INMHA), in partnership with the Canadian Cancer Society, will support research investigating the benefits and/or harms related to therapeutic use of cannabis in people living with cancer.

All applications must be submitted through CIHR鈥檚 . For more information, view the on the CIHR website.

CIHR will be hosting a webinar on April 18 to review with participants the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the page.

Questions may be addressed to Susan.Haydt@dal.ca

LOI due date: May 15, 2019